Acceptance rate 46%
Time to first decision 5 days*
Time to decision with review 50 days*

*approximate number of days


ACTA Pharmaceutica Sciencia 2003 , Vol 45 , Num 2
Triplicate Design Bioequivalence Studies
Nasir M. Idkaidek

Istanbul Medipol University